PMID- 16980044 OWN - NLM STAT- MEDLINE DCOM- 20061208 LR - 20060918 IS - 0041-1345 (Print) IS - 0041-1345 (Linking) VI - 38 IP - 7 DP - 2006 Sep TI - Hypoxia/reoxygenation up-regulated the expression of death receptor 5 and enhanced apoptosis in human hepatocyte line. PG - 2207-9 AB - OBJECTIVES: Ischemia-reperfusion injury (IRI) is a key factor that contributes to early and late dysfunction of liver graft. Although we have known that hepatocytes express death receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), the effects of TRAIL on hypoxia/reoxygenation (H/R)-mediated apoptosis are unclear. This study sought to examine the effects of H/R on TRAIL cytotoxicity, as a cause of primary hepatic graft dysfunction, delayed graft refunction, and chronic graft dysfunction. METHODS: Using an hepatocyte H/R model in vitro to mimic IRI in the grafted liver, normal human hepatocytes HL-7702 were exposed to hypoxia for 5 hours then reoxygenated for 0, 2, 4, 6, or 20 hours. In another experiment, hepatocytes were exposed to hypoxia for 0, 2, 4, 8, or 20 hours. Expressions of TRAIL-R2/Death receptor 5 (DR5) mRNA were measured by semiquantitative reverse-transcriptase polymerase chain reactions. After 16 hours of hypoxia, human hepatocytes were treated with TRAIL in different concentrations for 5 hours. The death of hepatocytes was confirmed by flow cytometer and methyl thiazolyl tetrazolium analysis. RESULT: After 5-hour hypoxia, the expressions of DR5 mRNA increased at all times of reoxygenation. DR5 mRNA was up-regulated from 0 hour after reoxygenation, reaching a peak value at 2 hours after reoxygenation compared with the normoxia cultured cells. Moreover, DR5 mRNA was up-regulated gradually following prolonged hypoxia. TRAIL-mediated cell killing was concentration-dependent being greater in the hypoxia treatment group compared to the normoxia group. CONCLUSIONS: H/R up-regulated the expression of DR5 and enhanced TRAIL-mediated apoptosis in an human hepatocyte line. The TRAIL pathway might play a critical role in hepatocyte apoptosis induced by IRI. FAU - Cao, L AU - Cao L AD - Lab of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu 610041, People's Republic of China. FAU - Li, Y AU - Li Y FAU - Cheng, F AU - Cheng F FAU - Li, S AU - Li S FAU - Long, D AU - Long D LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Transplant Proc JT - Transplantation proceedings JID - 0243532 RN - 0 (RNA, Messenger) RN - 0 (Receptors, TNF-Related Apoptosis-Inducing Ligand) RN - 0 (TNFRSF10B protein, human) SB - IM MH - Apoptosis MH - Cell Culture Techniques MH - Cell Hypoxia MH - Cell Line MH - Cell Survival MH - Gene Expression Regulation MH - Hepatocytes/cytology/*physiology MH - Humans MH - RNA, Messenger/genetics MH - Receptors, TNF-Related Apoptosis-Inducing Ligand/*genetics MH - Reperfusion Injury/physiopathology MH - Reverse Transcriptase Polymerase Chain Reaction EDAT- 2006/09/19 09:00 MHDA- 2006/12/12 09:00 CRDT- 2006/09/19 09:00 PHST- 2006/09/19 09:00 [pubmed] PHST- 2006/12/12 09:00 [medline] PHST- 2006/09/19 09:00 [entrez] AID - S0041-1345(06)00632-4 [pii] AID - 10.1016/j.transproceed.2006.06.014 [doi] PST - ppublish SO - Transplant Proc. 2006 Sep;38(7):2207-9. doi: 10.1016/j.transproceed.2006.06.014.